Form 8-K - Current report:
SEC Accession No. 0001129928-26-000006
Filing Date
2026-02-24
Accepted
2026-02-24 09:10:59
Documents
13
Period of Report
2026-02-24
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K oncy-20260224.htm   iXBRL 8-K 30216
2 EX-99.1 oncygobletupdate.htm EX-99.1 21943
  Complete submission text file 0001129928-26-000006.txt   171835

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oncy-20260224.xsd EX-101.SCH 1812
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT oncy-20260224_lab.xml EX-101.LAB 21597
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT oncy-20260224_pre.xml EX-101.PRE 12516
16 EXTRACTED XBRL INSTANCE DOCUMENT oncy-20260224_htm.xml XML 2808
Mailing Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada
Business Address 804, 322 - 11 AVENUE SW CALGARY Alberta, Canada 4036707377
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38512 | Film No.: 26667758
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)